Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115160162B reveals high-efficiency chiral synthesis. Delivers superior purity and scalable supply chain solutions for global pharmaceutical intermediate manufacturing.
Discover a novel Pd-catalyzed method for synthesizing biphenyl derivatives from aromatic carboxylic acids, offering significant cost reduction and environmental benefits for pharmaceutical intermediate manufacturing.
Novel synthesis route for pharmaceutical intermediate offering cost reduction and supply chain reliability via optimized catalytic hydrogenation.
Novel process for (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane synthesis offering superior yield and purity for reliable API intermediate supply chains.
Novel catalytic hydrogenation process ensures high purity and yield for 1-amino-1-deoxy-D-glucitol manufacturing with significant supply chain cost advantages.
Patent CN114835749B details a mild Grignard-based route for DuPhos and BPE ligands, eliminating hazardous P-H intermediates for safer large-scale manufacturing.
Patent CN108129357B details a novel one-pot method for producing high-purity anamorelin intermediates, offering significant safety and cost advantages for pharmaceutical supply chains.
Patent CN106146316A reveals high-selectivity boron catalysis for 1,2-diaryl ethylenediamines. Enables cost reduction and supply chain reliability in pharmaceutical intermediates manufacturing.
Patent CN109942514A reveals efficient Ir-catalyzed route for Atazanavir intermediate. Enables cost reduction in API manufacturing and reliable supply chain continuity.
Patent CN113045501B details a novel low-cost synthesis for 7-methyl-2-n-propyl-3H-benzimidazole-5-aldehyde, offering significant supply chain and purity advantages.
Advanced synthesis of 5-[(2R)-2-aminopropyl]-1-[3-(benzoyloxy)propyl]-7-cyano-1H-indole salt via oxidative dehydrogenation for superior pharmaceutical quality control and supply reliability.
Novel iron-catalyzed asymmetric hydrogenation using chiral quinoline imidazoline ligands offers high enantioselectivity and cost-effective alternatives to noble metals for pharmaceutical intermediates.
Patent CN111333573A details a robust asymmetric hydrogenation process for dextromethorphan intermediates, offering superior enantioselectivity and scalable manufacturing advantages.
Patent CN102264672A details a scalable route to chiral phenols using Ru-catalyzed transfer hydrogenation, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN112824421A reveals a robust chiral ligand synthesis route offering high enantioselectivity and TON up to 10000 for pharmaceutical manufacturing.
Patent CN110551037A reveals high-efficiency chiral amine synthesis. Discover cost reduction and supply chain advantages for agrochemical intermediate manufacturing.
Novel asymmetric hydrogenation route for moxifloxacin intermediates eliminates chiral resolution waste, offering high ee values and scalable production for global API manufacturers.
Novel dehydrogenation method for 3-oxo-4-azasteroids using Pd catalysts offers safer, scalable routes for API intermediates like Finasteride.
Novel ruthenium-catalyzed method ensures stable C-Si bonds and high yields for silicone acrylic ester manufacturing supply chain optimization.
Patent CN117049955B enables high-purity chiral ketone production. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.